Correlation Between Sarepta Therapeutics and Nanologix

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Sarepta Therapeutics and Nanologix at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sarepta Therapeutics and Nanologix into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sarepta Therapeutics and Nanologix, you can compare the effects of market volatilities on Sarepta Therapeutics and Nanologix and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sarepta Therapeutics with a short position of Nanologix. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sarepta Therapeutics and Nanologix.

Diversification Opportunities for Sarepta Therapeutics and Nanologix

0.04
  Correlation Coefficient

Significant diversification

The 3 months correlation between Sarepta and Nanologix is 0.04. Overlapping area represents the amount of risk that can be diversified away by holding Sarepta Therapeutics and Nanologix in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Nanologix and Sarepta Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sarepta Therapeutics are associated (or correlated) with Nanologix. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Nanologix has no effect on the direction of Sarepta Therapeutics i.e., Sarepta Therapeutics and Nanologix go up and down completely randomly.

Pair Corralation between Sarepta Therapeutics and Nanologix

Given the investment horizon of 90 days Sarepta Therapeutics is expected to generate 114.4 times less return on investment than Nanologix. But when comparing it to its historical volatility, Sarepta Therapeutics is 50.65 times less risky than Nanologix. It trades about 0.07 of its potential returns per unit of risk. Nanologix is currently generating about 0.16 of returns per unit of risk over similar time horizon. If you would invest  0.00  in Nanologix on October 11, 2024 and sell it today you would earn a total of  0.01  from holding Nanologix or generate 9.223372036854776E16% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Sarepta Therapeutics  vs.  Nanologix

 Performance 
       Timeline  
Sarepta Therapeutics 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Sarepta Therapeutics are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively stable basic indicators, Sarepta Therapeutics is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.
Nanologix 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Nanologix are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of fairly conflicting essential indicators, Nanologix showed solid returns over the last few months and may actually be approaching a breakup point.

Sarepta Therapeutics and Nanologix Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Sarepta Therapeutics and Nanologix

The main advantage of trading using opposite Sarepta Therapeutics and Nanologix positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sarepta Therapeutics position performs unexpectedly, Nanologix can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nanologix will offset losses from the drop in Nanologix's long position.
The idea behind Sarepta Therapeutics and Nanologix pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..

Other Complementary Tools

Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years